Your browser doesn't support javascript.
loading
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor.
Amelia, Tasia; van Veldhoven, Jacobus P D; Falsini, Matteo; Liu, Rongfang; Heitman, Laura H; van Westen, Gerard J P; Segala, Elena; Verdon, Grégory; Cheng, Robert K Y; Cooke, Robert M; van der Es, Daan; IJzerman, Adriaan P.
Affiliation
  • Amelia T; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • van Veldhoven JPD; School of Pharmacy, Bandung Institute of Technology, Jalan Ganesha 10, 40132 Bandung, Indonesia.
  • Falsini M; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Liu R; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • van Westen GJP; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Segala E; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Verdon G; Sosei Heptares, Steinmetz Building, Granta Park, Cambridge CB21 6DG, United Kingdom.
  • Cheng RKY; Sosei Heptares, Steinmetz Building, Granta Park, Cambridge CB21 6DG, United Kingdom.
  • Cooke RM; Sosei Heptares, Steinmetz Building, Granta Park, Cambridge CB21 6DG, United Kingdom.
  • van der Es D; Sosei Heptares, Steinmetz Building, Granta Park, Cambridge CB21 6DG, United Kingdom.
  • IJzerman AP; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
J Med Chem ; 64(7): 3827-3842, 2021 04 08.
Article in En | MEDLINE | ID: mdl-33764785
ABSTRACT
In this study, we determined the crystal structure of an engineered human adenosine A2A receptor bound to a partial agonist and compared it to structures cocrystallized with either a full agonist or an antagonist/inverse agonist. The interaction between the partial agonist, belonging to a class of dicyanopyridines, and amino acids in the ligand binding pocket inspired us to develop a small library of derivatives and assess their affinity in radioligand binding studies and potency and intrinsic activity in a functional, label-free, intact cell assay. It appeared that some of the derivatives retained the partial agonist profile, whereas other ligands turned into inverse agonists. We rationalized this remarkable behavior with additional computational docking studies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Receptor, Adenosine A2A / Adenosine A2 Receptor Agonists / Aminopyridines Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2021 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Receptor, Adenosine A2A / Adenosine A2 Receptor Agonists / Aminopyridines Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2021 Document type: Article Affiliation country: Netherlands